These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24253544)

  • 1. CHANCE trial: early short-term dual antiplatelet treatment for stroke prevention.
    Huang DY; Eisert WG
    Stroke; 2013 Dec; 44(12):3623-4. PubMed ID: 24253544
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antiplatelet therapy in acute ischemic stroke.
    Asdaghi N; Romano JG
    Curr Atheroscler Rep; 2015 Jul; 17(7):37. PubMed ID: 25990661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
    Bertelli M; Luongo R; Barcella L; Cavalli P
    Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532
    [No Abstract]   [Full Text] [Related]  

  • 5. Premorbid antiplatelet use and ischemic stroke outcomes.
    Li HF; Pan XD
    Neurology; 2006 Nov; 67(9):1723; author reply 1723. PubMed ID: 17101925
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].
    Barinagarrementeria F; Arauz A; Ruiz-Sandoval JL; Cantú C; Leyva A; Murillo L; Villarreal J; Vargas RD; Alegría MA; Merino JG; Romano J;
    Rev Invest Clin; 2010; 62(2):135-40. PubMed ID: 20597393
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of antiplatelet agents for prevention of ischemic stroke.
    Callison RC; Adams HP
    Neurol Clin; 2008 Nov; 26(4):1047-77, ix. PubMed ID: 19026902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EARLY antiplatelet treatment after ischaemic stroke.
    Adams HP
    Lancet Neurol; 2010 Feb; 9(2):131-3. PubMed ID: 20060782
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet therapy in ischemic stroke.
    Pongrácz E; Káposzta Z
    Expert Rev Neurother; 2005 Jul; 5(4):541-9. PubMed ID: 16026237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter by Zhang regarding article, "early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis".
    Zhang H
    Circulation; 2014 Aug; 130(8):e73. PubMed ID: 25135134
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to letter regarding article, "early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis".
    Wong KS; Wang Y; Leng X; Mao C; Tang J; Bath PM; Markus HS; Gorelick PB; Liu L; Lin W; Wang Y
    Circulation; 2014 Aug; 130(8):e74. PubMed ID: 25135135
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual antiplatelet treatment in acute ischemic stroke: Translating guidelines into clinical practice.
    Kollias A; Kyriakoulis KG; Lagou S
    Int J Clin Pract; 2020 Aug; 74(8):e13520. PubMed ID: 33145930
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulants versus antiplatelet agents for acute ischemic stroke.
    Hankey GJ; Berge E; Sandercock P
    Stroke; 2003 Jun; 34(6):1571-2. PubMed ID: 12764231
    [No Abstract]   [Full Text] [Related]  

  • 16. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 17. Meta-analysis finds benefit for dual antiplatelet therapy but limitations preclude changing standard mono antiplatelet therapy approach for acute non-cardioembolic ischaemic stroke or transient ischaemic attack.
    Aronow WS
    Evid Based Med; 2014 Jun; 19(3):94. PubMed ID: 24393716
    [No Abstract]   [Full Text] [Related]  

  • 18. New insights in antiplatelet therapy for patients with ischemic stroke.
    Chaturvedi S; Bhattacharya P
    Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Front-loading with clopidogrel plus aspirin followed by dual antiplatelet therapy in the prevention of early stroke recurrence.
    Censori B
    Expert Rev Neurother; 2014 Jul; 14(7):723-34. PubMed ID: 24881887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL
    J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.